EUVIMEDEUVIMED entdecken
Crossref

Different E-box binding transcription factors, similar neuro-developmental defects: ZEB2 (Mowat-Wilson syndrome) and TCF4 (Pitt-Hopkins syndrome)

Lize Meert, Judith C. Birkhoff, Andrea Conidi, Raymond A. Poot, Danny Huylebroeck

Rare Disease and Orphan Drugs Journal · 2022

DOI: 10.20517/rdodj.2022.03 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rare Disease and Orphan Drugs Journal, 2022. Verfasst von Lize Meert und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ZEB2 and TCF4 are transcription factors (TFs) whose locations in embryos overlap in many sites and developmental phases, including in the forebrain and its cortical neurons. De novo mutations cause the phenotypically overlapping, haploinsufficient Mowat-Wilson (MOWS, in the ZEB2 gene) and Pitt-Hopkins (PTHS, in TCF4) syndromes, which currently cannot be cured. Mutant alleles have been mapped and defects documented (also in brain function) in MOWS and PTHS patients. Appropriately designed mouse models and cells derived from these, as well as cellular models including cultured pluripotent cells, enable investigating the genetic and molecular mechanisms underlying the developmental deficiencies that manifest after birth in the nervous systems and their multiple cell types, as well as those of organs other than the brain, in MOWS and PTHS. Biochemical analyses of cell type-specific transcriptomic changes in these perturbation models as compared to control cells, the identification of the intact-factor dependent and direct target genes, and of partner proteins including chromatin modulators, are revealing complex and multiple modes of action that eventually will explain target gene selectivity for these TFs. Both TFs have also been found to operate in acute and chronic diseases and cell-based repair processes after tissue or organ injury. In addition, the defective function also arises from their aberrant gene expression, which will require a deeper investigation of how the transcription of these TF genes is regulated. Furthermore, these two factors genetically and biochemically interact. This review combines the essentials and recent progress for both TFs for the first time, with a focus on MOWS and PTHS.

Zitieren

APA

Meert, L., Birkhoff, J. C., Conidi, A., Poot, R. A., & Huylebroeck, D. (2022). Different E-box binding transcription factors, similar neuro-developmental defects: ZEB2 (Mowat-Wilson syndrome) and TCF4 (Pitt-Hopkins syndrome). Rare Disease and Orphan Drugs Journal. https://doi.org/10.20517/rdodj.2022.03

Vancouver

Meert L, Birkhoff JC, Conidi A, Poot RA, Huylebroeck D. Different E-box binding transcription factors, similar neuro-developmental defects: ZEB2 (Mowat-Wilson syndrome) and TCF4 (Pitt-Hopkins syndrome). Rare Disease and Orphan Drugs Journal. 2022. doi:10.20517/rdodj.2022.03

BibTeX
@article{Meert2022,
  author = {Meert, Lize and Birkhoff, Judith C. and Conidi, Andrea and Poot, Raymond A. and Huylebroeck, Danny},
  title = {Different E-box binding transcription factors, similar neuro-developmental defects: ZEB2 (Mowat-Wilson syndrome) and TCF4 (Pitt-Hopkins syndrome)},
  journal = {Rare Disease and Orphan Drugs Journal},
  year = {2022},
  doi = {10.20517/rdodj.2022.03}
}
Kostenlos starten →